Click for best price
Recombinant Erythropoietin Drugs Market Size, Share 2023
Erythropoietin (EPO), also known as haematopoietin or haemopoietin, is a glycoprotein cytokine secreted by the kidney in response to cellular hypoxia; it stimulates red blood cell production (erythropoiesis) in the bone marrow. Low levels of EPO (around 10 mU/mL) are constantly secreted sufficient to compensate for normal red blood cell turnover. Common causes of cellular hypoxia resulting in elevated levels of EPO (up to 10 000 mU/mL) include any anemia, and hypoxemia due to chronic lung disease.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. Liver production predominates in the fetal and perinatal period; renal production predominates in adulthood. It is homologous with thrombopoietin.
This report aims to provide a comprehensive presentation of the global market for Recombinant Erythropoietin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Erythropoietin Drugs. This report contains market size and forecasts of Recombinant Erythropoietin Drugs in global, including the following market information:
Global Recombinant Erythropoietin Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Recombinant Erythropoietin Drugs Market Sales, 2018-2023, 2024-2029, (KG)
Global top five Recombinant Erythropoietin Drugs companies in 2022 (%)
The global Recombinant Erythropoietin Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
rhEPO Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Erythropoietin Drugs include Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Roche, 3SBio Group, Celltrion, Inc, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd and LG Life Sciences Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Erythropoietin Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Erythropoietin Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (KG)
Global Recombinant Erythropoietin Drugs Market Segment Percentages, by Type, 2022 (%)
rhEPO
Erythropoiesis-Stimulating Agents (ESA)
Global Recombinant Erythropoietin Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (KG)
Global Recombinant Erythropoietin Drugs Market Segment Percentages, by Application, 2022 (%)
Chronic Kidney Disease
Cancer Related Anemia
Others
Global Recombinant Erythropoietin Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (KG)
Global Recombinant Erythropoietin Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Erythropoietin Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Erythropoietin Drugs revenues share in global market, 2022 (%)
Key companies Recombinant Erythropoietin Drugs sales in global market, 2018-2023 (Estimated), (KG)
Key companies Recombinant Erythropoietin Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Roche
3SBio Group
Celltrion, Inc
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd
LG Life Sciences Ltd
Biocon Limited
Intas Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Erythropoietin Drugs, market overview.
Chapter 2: Global Recombinant Erythropoietin Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Erythropoietin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Erythropoietin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Erythropoietin Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Recombinant Erythropoietin Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Erythropoietin Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Erythropoietin Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Erythropoietin Drugs Overall Market Size
2.1 Global Recombinant Erythropoietin Drugs Market Size: 2022 VS 2029
2.2 Global Recombinant Erythropoietin Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Erythropoietin Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Erythropoietin Drugs Players in Global Market
3.2 Top Global Recombinant Erythropoietin Drugs Companies Ranked by Revenue
3.3 Global Recombinant Erythropoietin Drugs Revenue by Companies
3.4 Global Recombinant Erythropoietin Drugs Sales by Companies
3.5 Global Recombinant Erythropoietin Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Erythropoietin Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Erythropoietin Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Erythropoietin Drugs Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Erythropoietin Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Erythropoietin Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Erythropoietin Drugs Market Size Markets, 2022 & 2029
4.1.2 rhEPO
4.1.3 Erythropoiesis-Stimulating Agents (ESA)
4.2 By Type - Global Recombinant Erythropoietin Drugs Revenue & Forecasts
4.2.1 By Type - Global Recombinant Erythropoietin Drugs Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Erythropoietin Drugs Revenue, 2024-2029
4.2.3 By Type - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Recombinant Erythropoietin Drugs Sales & Forecasts
4.3.1 By Type - Global Recombinant Erythropoietin Drugs Sales, 2018-2023
4.3.2 By Type - Global Recombinant Erythropoietin Drugs Sales, 2024-2029
4.3.3 By Type - Global Recombinant Erythropoietin Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Recombinant Erythropoietin Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Erythropoietin Drugs Market Size, 2022 & 2029
5.1.2 Chronic Kidney Disease
5.1.3 Cancer Related Anemia
5.1.4 Others
5.2 By Application - Global Recombinant Erythropoietin Drugs Revenue & Forecasts
5.2.1 By Application - Global Recombinant Erythropoietin Drugs Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Erythropoietin Drugs Revenue, 2024-2029
5.2.3 By Application - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Recombinant Erythropoietin Drugs Sales & Forecasts
5.3.1 By Application - Global Recombinant Erythropoietin Drugs Sales, 2018-2023
5.3.2 By Application - Global Recombinant Erythropoietin Drugs Sales, 2024-2029
5.3.3 By Application - Global Recombinant Erythropoietin Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Recombinant Erythropoietin Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Recombinant Erythropoietin Drugs Market Size, 2022 & 2029
6.2 By Region - Global Recombinant Erythropoietin Drugs Revenue & Forecasts
6.2.1 By Region - Global Recombinant Erythropoietin Drugs Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Erythropoietin Drugs Revenue, 2024-2029
6.2.3 By Region - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Recombinant Erythropoietin Drugs Sales & Forecasts
6.3.1 By Region - Global Recombinant Erythropoietin Drugs Sales, 2018-2023
6.3.2 By Region - Global Recombinant Erythropoietin Drugs Sales, 2024-2029
6.3.3 By Region - Global Recombinant Erythropoietin Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Recombinant Erythropoietin Drugs Revenue, 2018-2029
6.4.2 By Country - North America Recombinant Erythropoietin Drugs Sales, 2018-2029
6.4.3 US Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.4.4 Canada Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.4.5 Mexico Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Recombinant Erythropoietin Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Recombinant Erythropoietin Drugs Sales, 2018-2029
6.5.3 Germany Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.5.4 France Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.5.5 U.K. Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.5.6 Italy Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.5.7 Russia Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.5.9 Benelux Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Recombinant Erythropoietin Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Recombinant Erythropoietin Drugs Sales, 2018-2029
6.6.3 China Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.6.4 Japan Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.6.5 South Korea Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.6.7 India Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Recombinant Erythropoietin Drugs Revenue, 2018-2029
6.7.2 By Country - South America Recombinant Erythropoietin Drugs Sales, 2018-2029
6.7.3 Brazil Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.7.4 Argentina Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Erythropoietin Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Recombinant Erythropoietin Drugs Sales, 2018-2029
6.8.3 Turkey Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.8.4 Israel Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Erythropoietin Drugs Market Size, 2018-2029
6.8.6 UAE Recombinant Erythropoietin Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Recombinant Erythropoietin Drugs Major Product Offerings
7.1.4 Amgen Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Recombinant Erythropoietin Drugs Major Product Offerings
7.2.4 Johnson & Johnson Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Kyowa Hakko Kirin
7.3.1 Kyowa Hakko Kirin Company Summary
7.3.2 Kyowa Hakko Kirin Business Overview
7.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Major Product Offerings
7.3.4 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Kyowa Hakko Kirin Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Recombinant Erythropoietin Drugs Major Product Offerings
7.4.4 Roche Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 3SBio Group
7.5.1 3SBio Group Company Summary
7.5.2 3SBio Group Business Overview
7.5.3 3SBio Group Recombinant Erythropoietin Drugs Major Product Offerings
7.5.4 3SBio Group Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.5.5 3SBio Group Key News & Latest Developments
7.6 Celltrion, Inc
7.6.1 Celltrion, Inc Company Summary
7.6.2 Celltrion, Inc Business Overview
7.6.3 Celltrion, Inc Recombinant Erythropoietin Drugs Major Product Offerings
7.6.4 Celltrion, Inc Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Celltrion, Inc Key News & Latest Developments
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Company Summary
7.7.2 Teva Pharmaceutical Industries Ltd Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.8 F. Hoffmann-La Roche Ltd
7.8.1 F. Hoffmann-La Roche Ltd Company Summary
7.8.2 F. Hoffmann-La Roche Ltd Business Overview
7.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.8.4 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.8.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.9 LG Life Sciences Ltd
7.9.1 LG Life Sciences Ltd Company Summary
7.9.2 LG Life Sciences Ltd Business Overview
7.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.9.4 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.9.5 LG Life Sciences Ltd Key News & Latest Developments
7.10 Biocon Limited
7.10.1 Biocon Limited Company Summary
7.10.2 Biocon Limited Business Overview
7.10.3 Biocon Limited Recombinant Erythropoietin Drugs Major Product Offerings
7.10.4 Biocon Limited Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Biocon Limited Key News & Latest Developments
7.11 Intas Pharmaceuticals Ltd
7.11.1 Intas Pharmaceuticals Ltd Company Summary
7.11.2 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Business Overview
7.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.11.4 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Intas Pharmaceuticals Ltd Key News & Latest Developments
7.12 Sun Pharmaceutical Industries Ltd
7.12.1 Sun Pharmaceutical Industries Ltd Company Summary
7.12.2 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Business Overview
7.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.12.4 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.13 Dr. Reddy's Laboratories Ltd
7.13.1 Dr. Reddy's Laboratories Ltd Company Summary
7.13.2 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Business Overview
7.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.13.4 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Dr. Reddy's Laboratories Ltd Key News & Latest Developments
8 Global Recombinant Erythropoietin Drugs Production Capacity, Analysis
8.1 Global Recombinant Erythropoietin Drugs Production Capacity, 2018-2029
8.2 Recombinant Erythropoietin Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Erythropoietin Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Erythropoietin Drugs Supply Chain Analysis
10.1 Recombinant Erythropoietin Drugs Industry Value Chain
10.2 Recombinant Erythropoietin Drugs Upstream Market
10.3 Recombinant Erythropoietin Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Erythropoietin Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Erythropoietin Drugs in Global Market
Table 2. Top Recombinant Erythropoietin Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Erythropoietin Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Erythropoietin Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Erythropoietin Drugs Sales by Companies, (KG), 2018-2023
Table 6. Global Recombinant Erythropoietin Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Erythropoietin Drugs Price (2018-2023) & (USD/g)
Table 8. Global Manufacturers Recombinant Erythropoietin Drugs Product Type
Table 9. List of Global Tier 1 Recombinant Erythropoietin Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Erythropoietin Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Recombinant Erythropoietin Drugs Sales (KG), 2018-2023
Table 15. By Type - Global Recombinant Erythropoietin Drugs Sales (KG), 2024-2029
Table 16. By Application ? Global Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Recombinant Erythropoietin Drugs Sales (KG), 2018-2023
Table 20. By Application - Global Recombinant Erythropoietin Drugs Sales (KG), 2024-2029
Table 21. By Region ? Global Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Recombinant Erythropoietin Drugs Sales (KG), 2018-2023
Table 25. By Region - Global Recombinant Erythropoietin Drugs Sales (KG), 2024-2029
Table 26. By Country - North America Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Recombinant Erythropoietin Drugs Sales, (KG), 2018-2023
Table 29. By Country - North America Recombinant Erythropoietin Drugs Sales, (KG), 2024-2029
Table 30. By Country - Europe Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Recombinant Erythropoietin Drugs Sales, (KG), 2018-2023
Table 33. By Country - Europe Recombinant Erythropoietin Drugs Sales, (KG), 2024-2029
Table 34. By Region - Asia Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Recombinant Erythropoietin Drugs Sales, (KG), 2018-2023
Table 37. By Region - Asia Recombinant Erythropoietin Drugs Sales, (KG), 2024-2029
Table 38. By Country - South America Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Recombinant Erythropoietin Drugs Sales, (KG), 2018-2023
Table 41. By Country - South America Recombinant Erythropoietin Drugs Sales, (KG), 2024-2029
Table 42. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Sales, (KG), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Sales, (KG), 2024-2029
Table 46. Amgen Company Summary
Table 47. Amgen Recombinant Erythropoietin Drugs Product Offerings
Table 48. Amgen Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Recombinant Erythropoietin Drugs Product Offerings
Table 52. Johnson & Johnson Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Kyowa Hakko Kirin Company Summary
Table 55. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product Offerings
Table 56. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 57. Kyowa Hakko Kirin Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Recombinant Erythropoietin Drugs Product Offerings
Table 60. Roche Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 61. Roche Key News & Latest Developments
Table 62. 3SBio Group Company Summary
Table 63. 3SBio Group Recombinant Erythropoietin Drugs Product Offerings
Table 64. 3SBio Group Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 65. 3SBio Group Key News & Latest Developments
Table 66. Celltrion, Inc Company Summary
Table 67. Celltrion, Inc Recombinant Erythropoietin Drugs Product Offerings
Table 68. Celltrion, Inc Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 69. Celltrion, Inc Key News & Latest Developments
Table 70. Teva Pharmaceutical Industries Ltd Company Summary
Table 71. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 72. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 73. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 74. F. Hoffmann-La Roche Ltd Company Summary
Table 75. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 76. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 77. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 78. LG Life Sciences Ltd Company Summary
Table 79. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 80. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 81. LG Life Sciences Ltd Key News & Latest Developments
Table 82. Biocon Limited Company Summary
Table 83. Biocon Limited Recombinant Erythropoietin Drugs Product Offerings
Table 84. Biocon Limited Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 85. Biocon Limited Key News & Latest Developments
Table 86. Intas Pharmaceuticals Ltd Company Summary
Table 87. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 88. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 89. Intas Pharmaceuticals Ltd Key News & Latest Developments
Table 90. Sun Pharmaceutical Industries Ltd Company Summary
Table 91. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 92. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 93. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 94. Dr. Reddy's Laboratories Ltd Company Summary
Table 95. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 96. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 97. Dr. Reddy's Laboratories Ltd Key News & Latest Developments
Table 98. Recombinant Erythropoietin Drugs Production Capacity (KG) of Key Manufacturers in Global Market, 2021-2023 (KG)
Table 99. Global Recombinant Erythropoietin Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Recombinant Erythropoietin Drugs Production by Region, 2018-2023 (KG)
Table 101. Global Recombinant Erythropoietin Drugs Production by Region, 2024-2029 (KG)
Table 102. Recombinant Erythropoietin Drugs Market Opportunities & Trends in Global Market
Table 103. Recombinant Erythropoietin Drugs Market Drivers in Global Market
Table 104. Recombinant Erythropoietin Drugs Market Restraints in Global Market
Table 105. Recombinant Erythropoietin Drugs Raw Materials
Table 106. Recombinant Erythropoietin Drugs Raw Materials Suppliers in Global Market
Table 107. Typical Recombinant Erythropoietin Drugs Downstream
Table 108. Recombinant Erythropoietin Drugs Downstream Clients in Global Market
Table 109. Recombinant Erythropoietin Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Erythropoietin Drugs Segment by Type in 2022
Figure 2. Recombinant Erythropoietin Drugs Segment by Application in 2022
Figure 3. Global Recombinant Erythropoietin Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Erythropoietin Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Recombinant Erythropoietin Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Recombinant Erythropoietin Drugs Sales in Global Market: 2018-2029 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Erythropoietin Drugs Revenue in 2022
Figure 9. By Type - Global Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Recombinant Erythropoietin Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Recombinant Erythropoietin Drugs Price (USD/g), 2018-2029
Figure 13. By Application - Global Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Recombinant Erythropoietin Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Recombinant Erythropoietin Drugs Price (USD/g), 2018-2029
Figure 17. By Region - Global Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Recombinant Erythropoietin Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Recombinant Erythropoietin Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Recombinant Erythropoietin Drugs Sales Market Share, 2018-2029
Figure 23. US Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Recombinant Erythropoietin Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Recombinant Erythropoietin Drugs Sales Market Share, 2018-2029
Figure 28. Germany Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Recombinant Erythropoietin Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Recombinant Erythropoietin Drugs Sales Market Share, 2018-2029
Figure 37. China Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Recombinant Erythropoietin Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Recombinant Erythropoietin Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Recombinant Erythropoietin Drugs Production Capacity (KG), 2018-2029
Figure 53. The Percentage of Production Recombinant Erythropoietin Drugs by Region, 2022 VS 2029
Figure 54. Recombinant Erythropoietin Drugs Industry Value Chain
Figure 55. Marketing Channels
